Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: A randomized controlled trial

Obstetrics and Gynecology

Volumn 108, Issue 4, 2006, Pages 833-838

  Ehrenberg, Hugh M ^a,b   Mercer, Brian M ^c  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

AGE DISTRIBUTION; ANESTHESIA; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FISHER EXACT TEST; GESTATIONAL AGE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PARITY; PREECLAMPSIA; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEINURIA; PUERPERIUM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MAGNESIUM SULFATE; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; SEVERITY OF ILLNESS INDEX;

EID: 33749342034     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000236493.35347.d8     Document Type: Article

References (11)

1. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetrics and Gynecology. Obstet Gynecol 2002;99:159-67.
2. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 2004;190:1520-6.
3. Ascarelli MH, Johnson V, May WL, Martin RW, Martin JN Jr. Individually determined postpartum magnesium sulfate therapy with clinical parameters to safely and cost-effectively shorten treatment for pre-eclampsia. Am J Obstet Gynecol 1998;179:952-6.
4. Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN Jr. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy. Obstet Gynecol 2003;101:66-9.
5. Meyer NL, Mercer BM, Friedman SA, Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. Am J Obstet Gynecol 1994;170:137-41.
6. Durnwald C, Mercer B. A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia. Am J Obstet Gynecol 2003;189:848-52.
7. Isler CM, Barrilleaux PS, Rinehart BK, Magann EF, Martin JN Jr. Repeat postpartum magnesium sulfate administration for seizure prophylaxis: is there a patient profile predictive of need for additional therapy? J Matern Fetal Neonatal Med 2002;11:75-9.
8. Witlin AG, Friedman SA, Sibai BM. The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 1997;176:623-7.
9. Livingston JC, Livingston LW, Ramsey R, Mabie BC, Sibai BM. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003;101:217-20.
10. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-92.
11. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 2004;190:1520-6.